HBM9036

· Harbour BioMed (Guangzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HBM9036, covering 2023-02-24 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye [Phase 3]